Literature DB >> 12714694

Variation in the extent of microsatellite instability in human cell lines with defects in different mismatch repair genes.

N A Yamada1, A Castro, R A Farber.   

Abstract

Mismatch repair deficiency results in the elevation of mutation rates in tumors, which is especially pronounced in simple repeat sequences (microsatellites). We have investigated the relationship between microsatellite mutagenesis and certain combinations of mutations in mismatch repair genes, using a frameshift reversion assay to determine the spontaneous mutation rates of a dinucleotide microsatellite in two cancer cell lines, HCT116, which has defects in hMLH1 and hMSH3, and HEC-1-A, which has defects in hPMS2 and hMSH6. We found a 10-fold difference in mutation rates between these two cell lines. In addition, a mutant hPMS2 allele, PMS134, which has been reported to have a dominant negative effect, was expressed in mismatch repair-proficient telomerase-immortalized hTERT-1604 fibroblasts and mutation rates were determined. Expression of PMS134 did not elevate mutation rates in hTERT-1604. Combined, these results suggest that mutations in different mismatch repair genes can lead to varying degrees of microsatellite instability. It is also likely that there is heterogeneity in the mutations that are acquired in the absence of mismatch repair, such that some mismatch repair-defective cancer cells also contain mutations in other genes coding for proteins involved in the maintenance of genetic stability.

Entities:  

Mesh:

Year:  2003        PMID: 12714694     DOI: 10.1093/mutage/18.3.277

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  13 in total

1.  A novel role of vimentin filaments: binding and stabilization of collagen mRNAs.

Authors:  Azariyas A Challa; Branko Stefanovic
Journal:  Mol Cell Biol       Date:  2011-07-11       Impact factor: 4.272

2.  The E705K mutation in hPMS2 exerts recessive, not dominant, effects on mismatch repair.

Authors:  Suzanne M Deschênes; Guy Tomer; Megan Nguyen; Naz Erdeniz; Nicole C Juba; Natalia Sepúlveda; Jenna E Pisani; R Michael Liskay
Journal:  Cancer Lett       Date:  2006-10-09       Impact factor: 8.679

3.  Comparison of microsatellite status detection methods in colorectal carcinoma.

Authors:  Mei-Li Chen; Jie-Yu Chen; Jing Hu; Qian Chen; Li-Xia Yu; Bao-Rui Liu; Xiao-Ping Qian; Mi Yang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

4.  Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome.

Authors:  Michel De Vos; Bruce E Hayward; Susan Picton; Eamonn Sheridan; David T Bonthron
Journal:  Am J Hum Genet       Date:  2004-04-07       Impact factor: 11.025

5.  Serine-threonine kinase receptor-associated protein (STRAP) regulates translation of type I collagen mRNAs.

Authors:  Milica Vukmirovic; Zarko Manojlovic; Branko Stefanovic
Journal:  Mol Cell Biol       Date:  2013-08-05       Impact factor: 4.272

6.  Binding of LARP6 to the conserved 5' stem-loop regulates translation of mRNAs encoding type I collagen.

Authors:  Le Cai; Dillon Fritz; Lela Stefanovic; Branko Stefanovic
Journal:  J Mol Biol       Date:  2009-11-13       Impact factor: 5.469

7.  Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry.

Authors:  Jinru Shia
Journal:  J Mol Diagn       Date:  2008-06-13       Impact factor: 5.568

8.  Withaferin-A reduces type I collagen expression in vitro and inhibits development of myocardial fibrosis in vivo.

Authors:  Azariyas A Challa; Milica Vukmirovic; John Blackmon; Branko Stefanovic
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

9.  Heterozygosity increases microsatellite mutation rate, linking it to demographic history.

Authors:  William Amos; Jonathan Flint; Xin Xu
Journal:  BMC Genet       Date:  2008-11-14       Impact factor: 2.797

10.  Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms.

Authors:  Manav Korpal; Jacob Feala; Xiaoling Puyang; Jian Zou; Alex H Ramos; Jeremy Wu; Timm Baumeister; Lihua Yu; Markus Warmuth; Ping Zhu
Journal:  J Vis Exp       Date:  2015-12-09       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.